Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

9

Revenue 2014

Gilead Sciences

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Gilead Sciences' 2013 sales performance.

Pharma's reputation on the wane, say patient groups

Pharma's reputation on the wane, say patient groups

It ranked ahead ofand Gilead Sciences in the top five, with Grifols, Shire, Octapharma and Allergan jumping up the rankings.

Deal Watch: February 2017

Deal Watch: February 2017 Licence. 145. Sarepta Therapeutics/ Gilead Sciences. PRV received when EXONDYS 51 was FDA approved for Duchenne muscular dystrophy.

Gilead Sciences appoints general manager, Canada

Gilead Sciences appoints general manager, Canada Gilead Sciences has appointed Kennet Brysting as general manager of its Canadian operations, succeeding Ed Gudaitis. ... for at Gilead: empower and hold accountable, in a manner that also inspires and motivates.”.

2016: The year when deal-makers took stock?

2016: The year when deal-makers took stock? significant deal activity during the year and companies active in the area included Allergan, Gilead and Novartis.

Lilly claims first place for JAK inhibitor Olumiant in EU

Lilly claims first place for JAK inhibitor Olumiant in EU Other JAK inhibitors in late-stage development for RA that could reach the market in the next couple of years include Galapagos/Gilead Sciences' filgotinib, AbbVie's ABT-494 and Astellas'

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health offers a unique breadth and depth of experience, across everything from early stage product commercialisation, strategy and research,...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics